Holen Sie sich die Stockscreener-App
6.03
5.11%
-0.325
Handel nachbörslich:
6.03
Schlusskurs vom Vortag:
$6.355
Offen:
$6.22
24-Stunden-Volumen:
48,435
Relative Volume:
1.28
Marktkapitalisierung:
$8.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.35M
KGV:
-3.00
EPS:
-2.01
Netto-Cashflow:
$-36.91M
1W Leistung:
-14.83%
1M Leistung:
-15.31%
6M Leistung:
-61.17%
1J Leistung:
-60.57%
1-Tages-Spanne:
$5.622
$6.50
1-Wochen-Bereich:
$5.622
$7.05
52-Wochen-Spanne:
$5.622
$23.50
Galecto Inc Stock (GLTO) Company Profile
Firmenname
Galecto Inc
Sektor
Branche
Telefon
45-70-70-52-10
Adresse
75 STATE STREET, BOSTON
Vergleichen Sie GLTO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| GLTO | 6.03 | 8.31M | 0 | -38.35M | -36.91M | -2.01 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-11-23 | Eingeleitet | BofA Securities | Buy |
| 2020-11-23 | Eingeleitet | Credit Suisse | Outperform |
| 2020-11-23 | Eingeleitet | SVB Leerink | Outperform |
Galecto Inc Aktie (GLTO) Neueste Nachrichten
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Galecto Inc. (GLTO) Quarterly 10-Q Report - Quartzy
(GLTO) Investment Report - Stock Traders Daily
Galecto, Inc.’s Strategic Shift to Oncology and Liver Diseases: Navigating Risks and Opportunities - MSN
Galecto reports Q3 EPS ($3.39) vs ($7.50) - MSN
Galecto, Inc. Announces Strategic Shift and Financial Overview - MSN
Galecto Reports Third Quarter 2024 Financial Results - The Manila Times
(GLTO) On The My Stocks Page - Stock Traders Daily
Galecto price target raised to $10 from $9 at Oppenheimer - Yahoo Finance
How to Take Advantage of moves in (GLTO) - Stock Traders Daily
Galecto (NASDAQ:GLTO) Price Target Increased to $10.00 by Analysts at Oppenheimer - MarketBeat
Galecto (NASDAQ:GLTO) Given New $10.00 Price Target at Oppenheimer - MarketBeat
Galecto adds Dr. Amy Wechsler to Board of Directors By Investing.com - Investing.com Canada
Galecto stock hits 52-week low at $6.61 amid market challenges - Investing.com Canada
Galecto adds Dr. Amy Wechsler to Board of Directors - Investing.com
Galecto Appoints Dr. Amy Wechsler to Board - TipRanks
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler - The Manila Times
Galecto refocuses on cancer, acquires novel AML drug rights By Investing.com - Investing.com South Africa
Clene Inc (CLNN-Q) QuotePress Release - The Globe and Mail
Galecto stock hits 52-week low at $9.3 amid market challenges - Investing.com
Galecto stock hits 52-week low at $9.3 amid market challenges By Investing.com - Investing.com South Africa
Galecto Expands Oncology Portfolio with Strategic Acquisition - TipRanks
Galecto refocuses on cancer, acquires novel AML drug rights - Investing.com
Galecto Shares Slide on Leukemia Treatment Rights Acquisition - MarketWatch
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines - The Manila Times
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
TSX Composite Low Volatility (TXLV) QuotePress Release - The Globe and Mail
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
Charter Communications Inc (CHTR-Q) QuotePress Release - The Globe and Mail
Robusta Coffee 10-T (RMK26) Quote - The Globe and Mail
S&P GSCI Index (GNX) QuotePress Release - The Globe and Mail
TSX North American Pref Stock Index (STNU) QuotePress Release - The Globe and Mail
Nuscale Power Corp (SMR-N) QuotePress Release - The Globe and Mail
King Corn's Royal(s) Connection - The Globe and Mail
Trading (GLTO) With Integrated Risk Controls - Stock Traders Daily
Myelofibrosis Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Myers Squibb, Sumitomo - The Globe and Mail
Boehringer Gets The First Phase III Hit In IPF For A Decade - Scrip
Short Interest in Galecto, Inc. (NASDAQ:GLTO) Drops By 62.1% - Defense World
Skandinaviska Enskilda Banken AB publ Buys New Stake in GitLab Inc. (NASDAQ:GTLB) - MarketBeat
The Gabelli Convertible and Income Securities Fund (NYSE:GCV) Stock Price Passes Above 50 Day Moving Average of $3.83 - MarketBeat
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
Genenta Science (NASDAQ:GNTA) Stock Price Up 5.4% - MarketBeat
We Think Gamma Communications' (LON:GAMA) Healthy Earnings Might Be Conservative - Yahoo Finance
ABC Glofox records €34m loss due to start-up costs - MSN
Carlson Capital, L.P. Sells 50,000 Shares of Glatfelter Co. (NYSE:GLT) Stock - Defense World
Keeping an Eye on Gray Television, Inc. (GTN) After Insider Trading Activity - Knox Daily
GAMCO Investors (NYSE:GAMI) Sees Unusually-High Trading Volume - Defense World
Carlson entities sell Glatfelter Corp shares worth $91,000 - Investing.com
Ratio Review: Analyzing Gaotu Techedu Inc ADR (GOTU)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
GTBP stock touches 52-week low at $1.92 amid market challenges - Investing.com
GitLab Inc. (NASDAQ:GTLB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Finanzdaten der Galecto Inc-Aktie (GLTO)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):